Literature DB >> 18406241

The development of the polycystic ovary syndrome: family history as a risk factor.

M Kahsar-Miller1, R Azziz.   

Abstract

Three general genetic models for the development of the polycystic ovary syndrome (PCOS) can be proposed, namely: (1) the "single-gene Mendelian" model, which considers the majority of defects present in PCOS to be unique; (2) the "multifactorial" model, which suggests that the defects present in PCOS are not unique, and simply represent the conglomeration of abnormalities already present separately, and to a significant degree, in the general population (e.g. as in cardiovascular disease and non-insulin-dependent diabetes); and (3) the "variable expression-single gene" model, a modified version of the above two. Overall, our data support this third model, suggesting that PCOS is a familial disorder, with a single autosomal dominant gene effect, and a variable phenotype. Family history can then be considered as an important factor determining the risk of developing PCOS. Our preliminary data indicate that a woman's risk of developing PCOS is approximately 40% if her sister is affected. Alternatively, only 19% of mothers were affected, suggesting that the inheritance of PCOS may be preferentially paternal, although expanded clinical studies will be required to confirm these findings. Considering PCOS to be a dominant genetic disorder with a high degree of expressivity, we propose that the risk of developing the disorder is governed by family history and the degree of exposure to the selected environmental and/or other genetic influences.

Entities:  

Year:  1998        PMID: 18406241     DOI: 10.1016/s1043-2760(98)00021-6

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  12 in total

Review 1.  Polycystic ovary syndrome: What is it? Pathogenetic enigma and therapeutic dilemma.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 2.  Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

Authors:  A E Calogero; V Calabrò; M Catanuso; R A Condorelli; S La Vignera
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

Review 3.  Pharmacogenetics of follicle-stimulating hormone action.

Authors:  Maris Laan; Marina Grigorova; Ilpo T Huhtaniemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

4.  Further delineation of familial polycystic ovary syndrome (PCOS) via whole-exome sequencing: PCOS-related rare FBN3 and FN1 gene variants are identified.

Authors:  Cengiz Karakaya; Aylin Pelin Çil; Kaya Bilguvar; Tunahan Çakir; Mete Hakan Karalok; Recep Onur Karabacak; Ahmet Okay Caglayan
Journal:  J Obstet Gynaecol Res       Date:  2022-02-09       Impact factor: 1.697

Review 5.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

Review 6.  Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Bulent Yilmaz; Priyathama Vellanki; Baris Ata; Bulent Okan Yildiz
Journal:  Fertil Steril       Date:  2018-01-11       Impact factor: 7.329

7.  Intergenerational associations of chronic disease and polycystic ovary syndrome.

Authors:  Michael J Davies; Jennifer L Marino; Kristyn J Willson; Wendy A March; Vivienne M Moore
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

8.  The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS).

Authors:  Aylin Yaba; Necdet Demir
Journal:  J Ovarian Res       Date:  2012-11-27       Impact factor: 4.234

9.  Expression and activity of Rac1 is negatively affected in the dehydroepiandrosterone induced polycystic ovary of mouse.

Authors:  Vineet Kumar Maurya; Chadchan Sangappa; Vijay Kumar; Sahil Mahfooz; Archana Singh; Singh Rajender; Rajesh Kumar Jha
Journal:  J Ovarian Res       Date:  2014-03-14       Impact factor: 4.234

10.  The effect of cinnamon on polycystic ovary syndrome in a mouse model.

Authors:  Lei Dou; Yahong Zheng; Lu Li; Xiaowei Gui; Yajuan Chen; Meng Yu; Yi Guo
Journal:  Reprod Biol Endocrinol       Date:  2018-10-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.